Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PIK3R3 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | PABPN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | TIMELESS | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | RP11-729L2.2 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
mRNA | KDM6B | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | NLGN3 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
mRNA | KIFC3 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | NRBF2 | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-06 |
mRNA | NUP62 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | ELF2 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |